0001209191-17-021705.txt : 20170320 0001209191-17-021705.hdr.sgml : 20170320 20170320161444 ACCESSION NUMBER: 0001209191-17-021705 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170316 FILED AS OF DATE: 20170320 DATE AS OF CHANGE: 20170320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCMANUS MICHAEL A JR CENTRAL INDEX KEY: 0001051997 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 17701567 MAIL ADDRESS: STREET 1: 241-02 NORTHERN BLVD CITY: DOUGLASTON STATE: NY ZIP: 11362 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-16 0 0001000694 NOVAVAX INC NVAX 0001051997 MCMANUS MICHAEL A JR C/O NOVAVAX, INC. 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 1 0 0 0 Stock Option (Right to buy) 1.38 2017-03-16 4 A 0 80000 0.00 A 2018-03-16 2027-03-16 Common Stock 80000 80000 D One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan will vest one (1) year from the March 16, 2017 grant date subject to continued service on the Company's Board of Directors through the vesting date. /s/ John A. Herrmann III, Attorney-in-Fact 2017-03-20